These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1284499)

  • 1. Acetyl-L-carnitine prevents substance P loss in the sciatic nerve and lumbar spinal cord of diabetic animals.
    Di Giulio AM; Gorio A; Bertelli A; Mantegazza P; Ferraris L; Ramacci MT
    Int J Clin Pharmacol Res; 1992; 12(5-6):243-6. PubMed ID: 1284499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P.
    Di Giulio AM; Lesma E; Gorio A
    J Neurosci Res; 1995 Feb; 40(3):414-9. PubMed ID: 7538169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide alterations in autonomic diabetic neuropathy prevented by acetyl-L-carnitine.
    Gorio A; Di Giulio AM; Tenconi B; Donadoni L; Germani E; Bertelli A; Mantegazza P; Maccari F; Ramacci MT
    Int J Clin Pharmacol Res; 1992; 12(5-6):225-30. PubMed ID: 1284498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraspinal degenerative atrophy caused by sciatic nerve lesions prevented by acetyl-L-carnitine.
    Tenconi B; Donadoni L; Germani E; Bertelli A; Mantegazza P; Di Giulio AM; Ramacci MT; Gorio A
    Int J Clin Pharmacol Res; 1992; 12(5-6):263-7. PubMed ID: 1284500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of sensory function in diabetic rats by Neotrofin.
    Calcutt NA; Freshwater JD; Hauptmann N; Taylor EM; Mizisin AP
    Eur J Pharmacol; 2006 Mar; 534(1-3):187-93. PubMed ID: 16507305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counteraction on experimentally induced diabetic neuropathy by levocarnitine acetyl.
    Pacifici L; Bellucci A; Piovesan P; Maccari F; Gorio A; Ramacci MT
    Int J Clin Pharmacol Res; 1992; 12(5-6):231-6. PubMed ID: 1301403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.
    Malone JI; Lowitt S; Corsico N; Orfalian Z
    Int J Clin Pharmacol Res; 1992; 12(5-6):237-41. PubMed ID: 1301404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats.
    Nakamura J; Koh N; Sakakibara F; Hamada Y; Hara T; Sasaki H; Chaya S; Komori T; Nakashima E; Naruse K; Kato K; Takeuchi N; Kasuya Y; Hotta N
    J Pharmacol Exp Ther; 1998 Dec; 287(3):897-902. PubMed ID: 9864270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
    Saini AK; Kumar H S A; Sharma SS
    Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal cord interneuron degenerative atrophy caused by peripheral nerve lesions is prevented by serotonin depletion.
    Di Giulio AM; Tenconi B; Mannavola A; Mantegazza P; Schiavinato A; Gorio A
    J Neurosci Res; 1987; 18(3):443-8. PubMed ID: 2449537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy.
    Murakawa Y; Zhang W; Pierson CR; Brismar T; Ostenson CG; Efendic S; Sima AA
    Diabetes Metab Res Rev; 2002; 18(6):473-83. PubMed ID: 12469361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.
    Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima E; Sakamoto N
    J Pharmacol Exp Ther; 1996 Jan; 276(1):49-55. PubMed ID: 8558455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental diabetic neuropathy. Inhibition of protein mono-ADP-ribosylation prevents reduction of substance P axonal transport.
    Donadoni ML; Gavezzotti R; Borella F; Di Giulio AM; Gorio A
    J Pharmacol Exp Ther; 1995 Jul; 274(1):570-6. PubMed ID: 7542340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy.
    Hounsom L; Corder R; Patel J; Tomlinson DR
    Diabetologia; 2001 Apr; 44(4):424-8. PubMed ID: 11357471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denervation and hyperinnervation in the nervous system of diabetic animals. II. Monoaminergic and peptidergic alterations in the diabetic encephalopathy.
    Di Giulio AM; Tenconi B; La Croix R; Mantegazza P; Abbracchio MP; Cattabeni F; Gorio A
    J Neurosci Res; 1989 Nov; 24(3):362-8. PubMed ID: 2480454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
    Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor.
    Ohi T; Saita K; Furukawa S; Ohta M; Hayashi K; Matsukura S
    Exp Neurol; 1998 Jun; 151(2):215-20. PubMed ID: 9628756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-carnitine and acetyl-L-carnitine in human nerves from normal and diabetic subjects.
    Scarpini E; Doneda P; Pizzul S; Chiodi P; Ramacci MT; Baron P; Conti G; Sacilotto G; Arduini A; Scarlato G
    J Peripher Nerv Syst; 1996; 1(2):157-63. PubMed ID: 10975724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive and selective changes in neurotrophic factor expression and substance p axonal transport induced by perinatal diabetes: protective action of antioxidant treatment.
    Germani E; Lesma E; Di Giulio AM; Gorio A
    J Neurosci Res; 1999 Aug; 57(4):521-8. PubMed ID: 10440901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy.
    Hellweg R; Raivich G; Hartung HD; Hock C; Kreutzberg GW
    Exp Neurol; 1994 Nov; 130(1):24-30. PubMed ID: 7821393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.